These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33162887)

  • 1. Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease.
    Chiang CC; Korinek M; Cheng WJ; Hwang TL
    Front Pharmacol; 2020; 11():572009. PubMed ID: 33162887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
    Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Cremonesi G; Khan A; Mantelli F; Allegretti M; Balk R
    Eur J Immunol; 2023 Jan; 53(1):e2250010. PubMed ID: 36239164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the role of neutrophils in acute respiratory distress syndrome.
    Yang SC; Tsai YF; Pan YL; Hwang TL
    Biomed J; 2021 Aug; 44(4):439-446. PubMed ID: 33087299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils in COVID-19: recent insights and advances.
    Li J; Zhang K; Zhang Y; Gu Z; Huang C
    Virol J; 2023 Aug; 20(1):169. PubMed ID: 37533131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.
    Herrera VLM; Walkey AJ; Nguyen MQ; Gromisch CM; Mosaddhegi JZ; Gromisch MS; Jundi B; Lukassen S; Carstensen S; Denis R; Belkina AC; Baron RM; Pinilla-Vera M; Mueller M; Kimberly WT; Goldstein JN; Lehmann I; Shih AR; Eils R; Levy BD; Ruiz-Opazo N
    Sci Rep; 2022 Apr; 12(1):5583. PubMed ID: 35379853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment.
    Blanch-Ruiz MA; Ortega-Luna R; Gómez-García G; Martínez-Cuesta MÁ; Álvarez Á
    Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils during SARS-CoV-2 infection: Friend or foe?
    Castanheira FVS; Kubes P
    Immunol Rev; 2023 Mar; 314(1):399-412. PubMed ID: 36440642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature.
    Masso-Silva JA; Moshensky A; Lam MTY; Odish MF; Patel A; Xu L; Hansen E; Trescott S; Nguyen C; Kim R; Perofsky K; Perera S; Ma L; Pham J; Rolfsen M; Olay J; Shin J; Dan JM; Abbott RK; Ramirez S; Alexander TH; Lin GY; Fuentes AL; Advani I; Gunge D; Pretorius V; Malhotra A; Sun X; Duran J; Hepokoski M; Crotty S; Coufal NG; Meier A; Crotty Alexander LE
    Clin Infect Dis; 2022 Feb; 74(3):479-489. PubMed ID: 33988226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
    Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand.
    Ventura-Santana E; Ninan JR; Snyder CM; Okeke EB
    Front Immunol; 2022; 13():902206. PubMed ID: 35757734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated neutrophils in the initiation and progression of COVID-19: hyperinflammation and immunothrombosis in COVID-19.
    Zhao X; Zhou L; Kou Y; Kou J
    Am J Transl Res; 2022; 14(3):1454-1468. PubMed ID: 35422922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.
    Narasaraju T; Tang BM; Herrmann M; Muller S; Chow VTK; Radic M
    Front Pharmacol; 2020; 11():870. PubMed ID: 32581816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The counter-intuitive role of the neutrophil in the acute respiratory distress syndrome.
    Vassallo A; Wood AJ; Subburayalu J; Summers C; Chilvers ER
    Br Med Bull; 2019 Sep; 131(1):43-55. PubMed ID: 31504234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome.
    Bendib I; de Chaisemartin L; Granger V; Schlemmer F; Maitre B; Hüe S; Surenaud M; Beldi-Ferchiou A; Carteaux G; Razazi K; Chollet-Martin S; Mekontso Dessap A; de Prost N
    Anesthesiology; 2019 Apr; 130(4):581-591. PubMed ID: 30676417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--.
    Reyes L; A Sanchez-Garcia M; Morrison T; Howden AJM; Watts ER; Arienti S; Sadiku P; Coelho P; Mirchandani AS; Zhang A; Hope D; Clark SK; Singleton J; Johnston S; Grecian R; Poon A; McNamara S; Harper I; Fourman MH; Brenes AJ; Pathak S; Lloyd A; Blanco GR; von Kriegsheim A; Ghesquiere B; Vermaelen W; Cologna CT; Dhaliwal K; Hirani N; Dockrell DH; Whyte MKB; Griffith D; Cantrell DA; Walmsley SR
    Wellcome Open Res; 2021; 6():38. PubMed ID: 33997298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.